VERACYTE INC (VCYT) Stock News

USA - NASDAQ:VCYT - US92337F1075 - Common Stock

33.44 USD

+0.62 (+1.89%)

Last: 9/26/2025, 8:00:02 PM

33.34 USD

-0.1 (-0.3%)

After Hours: 9/26/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

VCYT Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Veracyte, Inc.

Veracyte Announces First Prospective Validation Data for Biomarker Predicting Hormone Therapy Benefit in Men with Recurrent Prostate Cancer Will Be Presented at ASTRO 2025

2 months ago - By: The Motley Fool

Veracyte (VCYT) Q2 Revenue Jumps 14%

2 months ago - By: Benzinga - Mentions: OEC VTLE DIN INSE ...

Earnings Scheduled For August 6, 2025

19 days ago - By: Veracyte, Inc.

Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting

a month ago - By: Zacks Investment Research

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

a month ago - By: Zacks Investment Research

Here's How Much a $1000 Investment in Veracyte Made 10 Years Ago Would Be Worth Today

a month ago - By: Veracyte, Inc.

Veracyte to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

5 months ago - By: Zacks Investment Research

What Makes Veracyte (VCYT) a New Buy Stock

a month ago - By: Veracyte, Inc.

Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer

a month ago - By: Zacks Investment Research - Mentions: NEO TEM

Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership

a month ago - By: Veracyte, Inc.

Veracyte Completes NIGHTINGALE Clinical Utility Trial Enrollment for Percepta Nasal Swab Lung Cancer Test

a month ago - By: Zacks Investment Research

Here's Why Veracyte (VCYT) is a Strong Momentum Stock

a month ago - By: Zacks Investment Research

Here's Why Veracyte (VCYT) is a Strong Growth Stock

2 months ago - By: Zacks Investment Research - Mentions: CAH MEDP WGS

VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up

2 months ago - By: Zacks Investment Research - Mentions: SGHT

Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates

2 months ago - By: Veracyte, Inc.

Veracyte Announces Second Quarter 2025 Financial Results

2 months ago - By: Yahoo Finance

Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion

2 months ago - By: Benzinga - Mentions: ADPT KTOS IRDM VEEV ...

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics

2 months ago - By: Veracyte, Inc.

Veracyte to Release Second Quarter 2025 Financial Results on August 6, 2025

3 months ago - By: Veracyte, Inc.

Veracyte Announces that Multiple Afirma GRID Studies Will Be Presented at ENDO 2025

3 months ago - By: Zacks Investment Research - Mentions: MYGN TEM

Tempus AI Boosts R&D Efforts Through Wide-Ranging Product Launches

4 months ago - By: Yahoo Finance - Mentions: TSLA PLTR ARKK AMD ...

Cathie Wood sells $22.8 million of hot stock near all-time highs

4 months ago - By: Yahoo Finance - Mentions: ENB IART NEM DOW ...

Enbridge Is One of the Largest Energy Companies by Market Cap. But Is It a Buy?

4 months ago - By: Zacks Investment Research - Mentions: IART

Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound?

4 months ago - By: Yahoo Finance - Mentions: REGN TBIO SCYX PEPG ...

Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency

4 months ago - By: Veracyte, Inc.

Veracyte Announces Multiple Abstracts To Be Presented at ASCO, Demonstrating Power of Decipher GRID to Advance New Prostate and Bladder Cancer Research

4 months ago - By: Veracyte, Inc.

Veracyte to Participate in Upcoming Investor Conferences

4 months ago - By: Zacks Investment Research - Mentions: CAH STE PAHC

Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally?

5 months ago - By: Yahoo Finance - Mentions: RXRX NVDA PRTA ROG ...

Why Recursion Pharmaceuticals Stock Plummeted 24% This Week

5 months ago - By: Zacks Investment Research - Mentions: BSX ANGO ITGR

Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up

5 months ago - By: Yahoo Finance - Mentions: FIS

Should I Take Money Out of My Roth IRA To Pay My Debt? Experts Weigh In